MedPage Today on MSN
FDA Halts Two Gene Therapy Trials After Child Develops Brain Tumor
Studies of Hunter and Hurler syndromes on hold ...
In certain groups of men, glucose-6-phosphate dehydrogenase (G6PD) deficiency was linked with an increased likelihood of severe COVID-19, a Veterans Affairs cohort study found. In Black men under 65, ...
An ultra-rare enzyme deficiency that keeps infants from achieving proper muscle function among other developmental delays now has its first FDA-approved treatment. The new product, a gene therapy ...
To protect this child from the same genetic disease that killed two older siblings, treating her as soon as she was born might only work so well, the doctors knew. So they dialed back the therapeutic ...
A Chiesi Farmaceutici drug for a rare enzyme deficiency is now approved by the FDA, making it the first U.S. treatment for a disorder that leads to a range of cognitive and muscle problems. The ...
Please provide your email address to receive an email when new articles are posted on . Click here to read the Cover Story, “After decades with only one option, new therapies emerge for congenial ...
AZoLifeSciences on MSN
DHPS enzyme deficiency impairs macrophage development and tissue repair
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer ...
If you’ve been struggling with bloating, gas, or cramping after meals and have gone down the rabbit hole of low-FODMAP diets and elimination protocols, you might be treating the wrong problem. While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results